BDMIX | OTCRX | BDMIX / OTCRX | |
Total Expense Ratio | 1.34 | 2.32 | 58% |
Annual Report Gross Expense Ratio | 1.42 | 2.49 | 57% |
Fund Existence | 13 years | 12 years | - |
Gain YTD | 11.213 | -23.452 | -48% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 2500 | 80,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 23.6M | 29,157% |
Annual Yield % from dividends | 9.94 | 0.58 | 1,706% |
Returns for 1 year | 13.58 | -26.45 | -51% |
Returns for 3 years | 60.06 | -11.30 | -532% |
Returns for 5 years | 60.34 | -5.74 | -1,050% |
Returns for 10 years | 56.03 | 0.75 | 7,438% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TADGX | 85.05 | 0.53 | +0.63% |
T. Rowe Price Dividend Growth Advisor | |||
PAXLX | 14.27 | 0.06 | +0.42% |
Impax Large Cap Fund Individual Investor | |||
FIRTX | 10.25 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate M | |||
BIPSX | 29.24 | -0.05 | -0.17% |
ProFunds Biotechnology UltraSector Svc | |||
GAHPX | 29.99 | -0.06 | -0.20% |
Goldman Sachs Emerging Markets Eq P |